Niels M. Verstegen
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Heterogeneous Activated B Cell Compartments Arising Early and Transiently After SARS-CoV-2 Vaccination.
Journal: European journal of immunology
Published: July 04, 2025
TCR-CD3 signal strength regulates plastic coexpression of IL-4 and IFN-γ in Tfh-like cells.
Journal: Frontiers in immunology
Published: August 15, 2024
Clinical and humoral response after SARS-CoV-2 breakthrough infection in patients receiving immunosuppressant therapy.
Journal: The Journal of allergy and clinical immunology
Published: December 23, 2023
T cell activation markers CD38 and HLA-DR indicative of non-seroconversion in anti-CD20-treated patients with multiple sclerosis following SARS-CoV-2 mRNA vaccination.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: July 14, 2023
Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity.
Journal: BMC infectious diseases
Published: November 15, 2022
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations.
Journal: Journal of autoimmunity
Published: October 24, 2022
Persistence of seroconversion at 6 months following primary immunisation in patients with immune-mediated inflammatory diseases.
Journal: Annals of the rheumatic diseases
Published: October 12, 2022
Single-cell analysis reveals dynamics of human B cell differentiation and identifies novel B and antibody-secreting cell intermediates.
Journal: eLife
Published: September 20, 2022
Breakthrough infections with the SARS-CoV-2 omicron (B.1.1.529) variant in patients with immune-mediated inflammatory diseases.
Journal: Annals of the rheumatic diseases
Published: June 09, 2022
Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies.
Journal: The Lancet. Rheumatology
Published: May 09, 2022
Last Updated: 09/26/2026